Patient No | Most severe endoscopic grade* pre-entry | Endoscopic grade† at entry | Medications at entry (mg/day) | Endoscopic grade † at 6 months | Medications at 6 months (mg/day) | Medications at 12 months (mg/day) |
---|---|---|---|---|---|---|
*Savary-Miller classification. | ||||||
† Los Angeles classification. | ||||||
OME, omeprazole; PAN, pantoprazole; RAN, ranitidine; FAM, famotidine. | ||||||
‡Underwent laparoscopic fundoplication at nine months. | ||||||
1 | Normal | 0 | RAN 600 | 0 | None | None |
2 | Normal | 0 | OME 80 | 0 | None | None |
3 | II | 0 | OME 20 | A | OME 20 | OME 20 |
4 | II | A | OME 20 | A | None | None |
5 | Normal | 0 | FAM 80 | A | None | None |
6 | I | 0 | OME 80 | 0 | None | None |
7 | II | 0 | OME 20 | A | None | RAN 150 |
8 | II | A | RAN 300 | A | None | None |
9 | II | 0 | OME 20 | 0 | RAN 150 | RAN 150 |
10 | III | 0 | OME 20 | 0 | None | None |
11 | III | B | OME 80 | A | RAN 300 | RAN 300 |
12 | II | 0 | OME 20 | A | None | None |
13 | II | 0 | OME 20 | 0 | None | None |
14 | III | B | OME 20 | A | RAN 300 | None |
15 | III | 0 | OME 20 | A | None | None |
16 | II | 0 | OME 20 | 0 | None | None |
17 | II | C | OME 20 | A | None | None |
18 | Normal | 0 | RAN 300 | 0 | None | RAN 150 |
19 | Normal | 0 | PAN 80 | 0 | PAN 40 | None‡ |
20 | II | 0 | OME 20 | 0 | None | RAN 300 |